Association of demographics, HCV co‐infection, HIV‐1 subtypes and genetic clustering with late HIV diagnosis: a retrospective analysis from the Japanese Drug Resistance HIV‐1 Surveillance Network

Author:

Otani Machiko12ORCID,Shiino Teiichiro13,Hachiya Atsuko456,Gatanaga Hiroyuki7,Watanabe Dai8,Minami Rumi9,Nishizawa Masako1,Teshima Takanori1011,Yoshida Shigeru12,Ito Toshihiro13,Hayashida Tsunefusa7,Koga Michiko2,Nagashima Mami14,Sadamasu Kenji14,Kondo Makiko15,Kato Shingo16,Uno Shunsuke16,Taniguchi Toshibumi17,Igari Hidetoshi17,Samukawa Sei18,Nakajima Hideaki18,Yoshino Yusuke19,Horiba Masahide20,Moro Hiroshi21,Watanabe Tamayo22,Imahashi Mayumi4,Yokomaku Yoshiyuki4,Mori Haruyo23,Fujii Teruhisa24,Takada Kiyonori25,Nakamura Asako26,Nakamura Hideta27,Tateyama Masao27,Matsushita Shuzo28,Yoshimura Kazuhisa14,Sugiura Wataru3,Matano Tetsuro12ORCID,Kikuchi Tadashi1,

Affiliation:

1. AIDS Research Center National Institute of Infectious Diseases Tokyo Japan

2. Institute of Medical Science University of Tokyo Tokyo Japan

3. Center for Clinical Sciences National Center for Global Health and Medicine Tokyo Japan

4. Clinical Research Center National Hospital Organization Nagoya Medical Center Aichi Japan

5. Department of Laboratory Medicine Tokyo Medical University Tokyo Japan

6. Department of Clinical Laboratory Sciences Nitobe Bunka College Tokyo Japan

7. AIDS Clinical Center National Center for Global Health and Medicine Tokyo Japan

8. AIDS Medical Center National Hospital Organization Osaka National Hospital Osaka Japan

9. Internal Medicine Clinical Research Institute National Hospital Organization Kyushu Medical Center Fukuoka Japan

10. Department of Clinical Laboratories Hokkaido University Hospital Hokkaido Japan

11. Department of Hematology, Faculty of Medicine Hokkaido University Hokkaido Japan

12. School of Medical Technology Health Sciences University of Hokkaido Hokkaido Japan

13. Department of Infectious Diseases National Hospital Organization Sendai Medical Center Miyagi Japan

14. Tokyo Metropolitan Institute of Public Health Tokyo Japan

15. Division of Microbiology Kanagawa Prefectural Institute of Public Health Kanagawa Japan

16. Department of Infectious Diseases Keio University School of Medicine Tokyo Japan

17. Department of Infection Control Chiba University Hospital Chiba Japan

18. Department of Hematology and Clinical Immunology Yokohama City University School of Medicine Kanagawa Japan

19. Department of Microbiology Teikyo University School of Medicine Tokyo Japan

20. Department of Respiratory Medicine National Hospital Organization Higashisaitama National Hospital Saitama Japan

21. Department of Respiratory Medicine and Infectious Diseases Niigata University Graduate School of Medical and Dental Sciences Niigata Japan

22. Department of Immunology and Infectious Disease Ishikawa Prefectural Central Hospital Ishikawa Japan

23. Division of Microbiology Osaka Institute of Public Health Osaka Japan

24. Division of Transfusion Medicine Hiroshima University Hospital Hiroshima Japan

25. Postgraduate Clinical Training Center Ehime University Hospital Ehime Japan

26. Division of Virology Fukuoka Institute of Health and Environmental Sciences Fukuoka Japan

27. Department of Infectious, Respiratory, and Digestive Medicine, Control and Prevention of Infectious Diseases, Graduate School of Medicine University of the Ryukyus Okinawa Japan

28. Joint Research Center for Human Retrovirus Infection Kumamoto University Kumamoto Japan

Abstract

AbstractIntroductionLate diagnosis of the human immunodeficiency virus (HIV) is a major concern epidemiologically, socially and for national healthcare systems. Although the association of certain demographics with late HIV diagnosis has been reported in several studies, the association of other factors, including clinical and phylogenetic factors, remains unclear. In the present study, we conducted a nationwide analysis to explore the association of demographics, clinical factors, HIV‐1 subtypes/circulating recombinant form (CRFs) and genetic clustering with late HIV diagnosis in Japan, where new infections mainly occur among young men who have sex with men (MSM) in urban areas.MethodsAnonymized data on demographics, clinical factors and HIV genetic sequences from 39.8% of people newly diagnosed with HIV in Japan were collected by the Japanese Drug Resistance HIV‐1 Surveillance Network from 2003 to 2019. Factors associated with late HIV diagnosis (defined as HIV diagnosis with a CD4 count <350 cells/μl) were identified using logistic regression. Clusters were identified by HIV‐TRACE with a genetic distance threshold of 1.5%.ResultsOf the 9422 people newly diagnosed with HIV enrolled in the surveillance network between 2003 and 2019, 7752 individuals with available CD4 count at diagnosis were included. Late HIV diagnosis was observed in 5522 (71.2%) participants. The overall median CD4 count at diagnosis was 221 (IQR: 62–373) cells/μl. Variables independently associated with late HIV diagnosis included age (adjusted odds ratio [aOR] 2.21, 95% CI 1.88–2.59, ≥45 vs. ≤29 years), heterosexual transmission (aOR 1.34, 95% CI 1.11–1.62, vs. MSM), living outside of Tokyo (aOR 1.18, 95% CI 1.05–1.32), hepatitis C virus (HCV) co‐infection (aOR 1.42, 95% CI 1.01–1.98) and not belonging to a cluster (aOR 1.30, 95% CI 1.12–1.51). CRF07_BC (aOR 0.34, 95% CI 0.18–0.65, vs. subtype B) was negatively associated with late HIV diagnosis.ConclusionsIn addition to demographic factors, HCV co‐infection, HIV‐1 subtypes/CRFs and not belonging to a cluster were independently associated with late HIV diagnosis in Japan. These results imply the need for public health programmes aimed at the general population, including but not limited to key populations, to encourage HIV testing.

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference53 articles.

1. Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016

2. World Health Organization.Guideline on when to start antiretroviral therapy and on pre‐exposure prophylaxis for HIV guidelines [Internet].2015[cited 2021 Jul 6]. Available from:https://apps.who.int/iris/handle/10665/186275

3. Late Presentation for Human Immunodeficiency Virus Care in the United States and Canada

4. UK Health Security Agency.HIV: annual data tables [Internet].2021[cited 2022 Mar 18]. Available from:https://www.gov.uk/government/statistics/hiv‐annual‐data‐tables

5. Baseline CD4 Cell Counts of Newly Diagnosed HIV Cases in China: 2006–2012

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3